Lief Labs Appoints International Finance and Business Strategist as Chief Financial Officer

Helder Guimarães joins firm to support Lief’s continued rapid growth and expansion

VALENCIA, CA / ACCESSWIRE / May 18, 2020 / Lief Labs, a premier formulation and product development innovator and manufacturer of dietary supplements, is pleased to announce the firm’s appointment of former Lief board member, Helder Guimarães, as Chief Financial Officer (CFO). In this newly established role at Lief, Guimarães will lead a team of financial professionals to drive and support the firm’s mission of expanding its manufacturing operation into a world class technology-driven company.

Guimarães brings to Lief over 14 years of experience as an innovative business strategist. His extensive financial expertise includes working with small to midsize organizations in the energy and technology sectors in the U.S. and internationally, including Portugal, Germany and Canada. His previous experience includes finance and business strategy roles at Envent Corporation, as well as senior finance positions at other firms, such as Primetag, General Electric, Martifer and Crowe Horwath.

“Helder has served as a board member for Lief in the past and we are excited to welcome him back to join a team of executives in both Nathan Cox, our VP of Sales & Business Development, and Dieng Bui, VP of Operations, to further propel the firm’s growth, expansion and momentum,” said Adel Villalobos, CEO & Founder of Lief. “Together, this experienced leadership team will manage a talented farm system of future leaders that will drive Lief’s continued innovation, passion for quality assurance, transparency and our overall contributions as champions and stewards of the nutritional supplement industry.”

“I am delighted to be joining Lief Labs at such an exciting time for the Company. Lief is expanding its business and customer base rapidly, both within the U.S. and internationally; consolidating this progress and supporting continued growth will be key in the near future. I’m very excited to be a part of this project and to be working with Adel and the team again, to help bring to fruition his vision of taking the company to the next level.”

Guimarães is a graduate of the UCLA – Anderson School of Management Executive Program and he earned his bachelor’s degree in Economics at the University of Minho, Portugal.

About Lief Labs

Lief Labs is a premier formulation and product development innovator and manufacturer of dietary supplements with 170 employees. Our in-house Product Development and R&D team creates the best tasting and most cutting-edge formulations of supplements. Lief also houses a state of the art, full-service **cGMP** manufacturing facility, which offers custom solutions for a multitude of supplement categories. Lief collaborates with entrepreneurial firms to help them build premier brands. Our turnkey solutions allow us to engage in seamless partnerships that help brands with scalability and sustainable growth. The company is based in Valencia, CA. To learn more, please visit www.lieflabs.com.

**Current Good Manufacturing Practice**

For Media Inquiries, please contact:
Cathy Loos
Loos & Co. Communications
+1-347-334-4135
cloos@looscomm.com

SOURCE: Lief Labs

View source version on accesswire.com:
https://www.accesswire.com/590017/Lief-Labs-Appoints-International-Finance-and-Business-Strategist-as-Chief-Financial-Officer

Staff

Recent Posts

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB:…

2 hours ago

Mobile-health Network Solutions Announces Closing of Initial Public Offering

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or “the Company”), a…

2 days ago

Biomerica Reports Third Quarter 2024 Financial Results

Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst…

2 days ago

American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione

SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS)…

2 days ago

Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results

Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS…

2 days ago

Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome

Conference call now scheduled for Monday, April 15 at 8:00 a.m. ET Updated registration link…

2 days ago